These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26037881)

  • 21. Therapeutic potential of new second generation antipsychotics for major depressive disorder.
    McElroy SL; Guerdjikova A; Mori N; Keck PE
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1527-44. PubMed ID: 21105856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three cases of hypomania and one case of mania during aripiprazole treatment.
    Viikki M; Valtonen HM; Leinonen E
    Pharmacopsychiatry; 2011 Mar; 44(2):78-81. PubMed ID: 21157696
    [No Abstract]   [Full Text] [Related]  

  • 23. The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study.
    Fisher LB; Fava M; Doros GD; Alpert JE; Henry M; Huz I; Freeman MP
    J Nerv Ment Dis; 2015 Oct; 203(10):762-8. PubMed ID: 26348584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective treatment of premenstrual violence in major depression: augmentation with aripiprazole.
    Yao YC; Chiang PH; Hsiao MC; Liu CY
    Chang Gung Med J; 2008; 31(4):402-6. PubMed ID: 18935799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
    Boulton DW; Balch AH; Royzman K; Patel CG; Berman RM; Mallikaarjun S; Reeves RA
    J Psychopharmacol; 2010 Apr; 24(4):537-46. PubMed ID: 18832427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
    Goforth HW; Carroll BT
    J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
    [No Abstract]   [Full Text] [Related]  

  • 27. Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting.
    Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS
    Int Clin Psychopharmacol; 2014 Mar; 29(2):116-9. PubMed ID: 24108149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central sleep apnea in a geriatric patient treated with aripiprazole.
    Kohen I; Sarcevic A
    Am J Ther; 2009; 16(2):197-8. PubMed ID: 19300045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole-related subcortical growth in a patient with major depressive disorder and panic disorder.
    Lai CH
    J Clin Psychopharmacol; 2010 Aug; 30(4):474-6. PubMed ID: 20631573
    [No Abstract]   [Full Text] [Related]  

  • 30. Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder.
    Lai CH
    J Clin Psychiatry; 2010 Mar; 71(3):360-2. PubMed ID: 20331938
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs for depression and bipolar disorder.
    Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of psychotic depression in the elderly compared with nonpsychotic depression.
    Kok R; Heeren T; Nolen W
    J Clin Psychopharmacol; 2010 Aug; 30(4):465-7. PubMed ID: 20631567
    [No Abstract]   [Full Text] [Related]  

  • 33. Current evidence for aripiprazole as augmentation therapy in major depressive disorder.
    Khan A
    Expert Rev Neurother; 2008 Oct; 8(10):1435-47. PubMed ID: 18928339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract]   [Full Text] [Related]  

  • 35. Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma.
    Steinhagen CK
    Psychosomatics; 2007; 48(4):350-1. PubMed ID: 17600173
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of Huntington Disease and Comorbid Trichotillomania With Aripiprazole.
    Howard AK; Krishnamoorthy A; Leavitt BR; Raymond LA; Weissman CR
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):e211-2. PubMed ID: 26222972
    [No Abstract]   [Full Text] [Related]  

  • 37. Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.
    Han C; Wang SM; Kwak KP; Won WY; Lee H; Chang CM; Tang TC; Pae CU
    J Psychiatr Res; 2015; 66-67():84-94. PubMed ID: 26013203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective Use of Aripiprazole Augmentation in a Clozapine-Treated Adolescent with Autism Spectrum Disorder.
    Gunes H; Tanidir C; Erdogan A
    J Child Adolesc Psychopharmacol; 2015 Nov; 25(9):727-8. PubMed ID: 26402582
    [No Abstract]   [Full Text] [Related]  

  • 39. Pica in an Adolescent with Autism Spectrum Disorder Responsive to Aripiprazole.
    Hergüner A; Hergüner S
    J Child Adolesc Psychopharmacol; 2016 Feb; 26(1):80-1. PubMed ID: 26780755
    [No Abstract]   [Full Text] [Related]  

  • 40. Functional Vomiting Treated Successfully with Aripiprazole in a Child with Autism Spectrum Disorder.
    Açıkel B; Yar A; Hergüner S
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):177-8. PubMed ID: 26938577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.